1. American Association of Endodontists. Glossary of endodontic terms. 7th ed.p. pp40. 2003.
2. Cox CF, Su¨bay RK, Ostro E, Suzuki S, Suzuki SH. Tunnel defects in dentin bridges: their formation following direct pulp capping. Oper Dent. 1996; 21:4–11.
3. Cox CF, Hafez AA, Akimoto N, Otsuki M, Suzuki S, Tarim B. Biocompatibility of primer, adhesive and resin composite systems on non-exposed and exposed pulps of non-human primate teeth. Am J Dent. 1998; 11(Supplement):55–63.
4. Cox CF, Tarim B, Kopel H, Gu¨rel G, Hafez A. Technique sensitivity: biological factors contributing to clinical success with various restorative materials. Adv Dent Res. 2001; 15:85–90.
Article
5. Yun YR, Yang IS, Hwang YC, Hwang IN, Choi HR, Yoon SJ, Kim SH, Oh WM. Pulp response of mineral trioxide aggregate, calcium sulfate or calcium hydroxide. J Kor Acad Cons Dent. 2007; 32:95–101.
Article
6. Bae JH, Kim YG, Yoon PY, Cho BH, Choi YH. Pulp response of beagle dog to direct pulp capping materials: histological study. J Kor Acad Cons Dent. 2010; 35:5–12.
Article
7. Dominguez MS, Witherspoon DE, Gutmann JL, Opperman LA. Histological and scanning electron microscopy assessment of various vital pulp-therapy materials. J Endod. 2003; 29:324–333.
Article
8. Ford TR, Torabinejad M, Abedi HR, Bakland LK, Kariyawasam SP. Using mineral trioxide aggregate as a pulp-capping material. J Am Dent Assoc. 1996; 127:1491–1494.
Article
9. Faraco IM Jr, Holland R. Response of the pulp of dogs to capping with mineral trioxide aggregate or a calcium hydroxide cement. Dent Traumatol. 2001; 17:163–166.
Article
10. Hauman CH, Love RM. Biocompatibility of dental materials used in contemporary endodontic therapy: a review. Part 2. Root canal-filling materials. Int Endod J. 2003; 36:147–160.
11. Aeinehchi M, Eslami B, Ghanbariha M, Saffar AS. Mineral trioxide aggregate (MTA) and calcium hydroxide as pulp-capping agents in human teeth: a preliminary report. Int Endod J. 2003; 36:225–231.
Article
12. Accorinte Mde L, Holland R, Reis A, Bortoluzzi MC, Murata SS, Dezan E Jr, Souza V, Alessandro LD. Evaluation of mineral trioxide aggregate and calcium hydroxide cement as pulp-capping agents in human teeth. J Endod. 2008; 34:1–6.
13. Iwamoto CE, Adachi E, Pameijer CH, Barnes D, Romberg EE, Jeffries S. Clinical and histological evaluation of white ProRoot MTA in direct pulp capping. Am J Dent. 2006; 19:85–90.
14. Yasuda Y, Ogawa M, Arakawa T, Kadowaki T, Saito T. The effect of mineral trioxide aggregate on the mineralization ability of rat dental pulp cells: an in vitro study. J Endod. 2008; 34:1057–1060.
Article
15. Andelin WE, Shabahang S, Wright K, Torabinejad M. Identification of hard tissue after experimental pulp capping using dentin sialoprotein (DSP) as a marker. J Endod. 2003; 29:646–650.
Article
16. Kuratate M, Yoshiba K, Shigetani Y, Yoshiba N, Ohshima H, Okiji T. Immunohistochemical analysis of nestin, osteopontin, and proliferating cells in the reparative process of exposed dental pulp capped with mineral trioxide aggregate. J Endod. 2008; 34:970–974.
Article
17. Min KS, Yang SH, Kim EC. The combined effect of mineral trioxide aggregate and enamel matrix derivative on odontoblastic differentiation in human dental pulp cells. J Endod. 2009; 35:847–851.
Article
18. Shi S, Robey PG, Gronthos S. Comparison of human dental pulp and bone marrow stromal stem cells by cDNA microarray analysis. Bone. 2001; 29:532–539.
Article
19. McLachlan JL, Smith AJ, Bujalska IJ, Cooper PR. Gene expression profiling of pulpal tissue reveals the molecular complexity of dental caries. Biochim Biophys Acta. 2005; 1741:271–281.
Article
20. Syudo M, Yamada S, Yanagiguchi K, Matsunaga T, Hayashi Y. Early gene expression analyzed by a genome microarray and real-time PCR in osteoblasts cultured with a 4-META/MMA-TBB adhesive resin sealer. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2009; 107:e77–81.
Article
21. Martinez ZR, Naruishi K, Yamashiro K, Myokai F, Yamada T, Matsuura K, Namba N, Arai H, Sasaki J, Abiko Y, Takashiba S. Gene profiles during root canal treatment in experimental rat periapical lesions. J Endod. 2007; 33:936–943.
Article
22. Yokose S, Kadokura H, Tajima Y, Fujieda K, Katayama I, Matsuoka T, Katayama T. Establishment and characterization of a culture system for enzymatically released rat dental pulp cells. Calcif Tissue Int. 2000; 66:139–144.
Article
23. Kim YB, Shon WJ, Lee WC, Kum KY, Baek SH, Bae KS. Gene Expression Profiling in Human Dental Pulp Cells Treated with Mineral Trioxide Aggregate. J Kor Acad Cons Dent. 35:152–163. 2010.
Article
24. Goldberg M, Six N, Decup F, Lasfargues JJ, Salih E, Tompkins K, Veis A. Bioactive molecules and the future of pulp therapy. Am J Dent. 2003; 16:66–76.
25. Almushayt A, Narayanan K, Zaki AE, George A. Dentin matrix protein 1 induces cytodifferentiation of dental pulp stem cells into odontoblasts. Gene Ther. 2006; 13:611–620.
Article
26. Goldberg M, Farges JC, Lacerda-Pinheiro S, Six N, Jegat N, Decup F, Septier D, Carrouel F, Durand S, Chaussain-Miller C, Denbesten P, Veis A, Poliard A. Inflammatory and immunological aspects of dental pulp repair. Pharmacol Res. 2008; 58:137–147.
Article
27. Reddi AH. Bone morphogenetic proteins: an unconventional approach to isolation of first mammalian mor-phogens. Cytokine Growth Factor Rev. 1997; 8:11–20.
Article
28. Gu K, Smoke RH, Rutherford RB. Expression of genes for bone morphogenetic proteins and receptors in human dental pulp. Arch Oral Biol. 1996; 41:919–923.
Article
29. Nakashima M, Nagasawa H, Yamada Y, Reddi AH. Regulatory role of transforming growth factor-β, bone morphogenetic protein-2, and protein-4 on gene expression of extracellular matrix proteins and differentiation of dental pulp cells. Dev Biol. 1994; 162:18–28.
Article
30. Saito T, Ogawa M, Hata Y, Bessho K. Acceleration effect of human recombinant bone morphogenetic protein-2 on differentiation of human pulp cells into odon-toblasts. J Endod. 2004; 30:205–208.
Article
31. Yasuda Y, Ogawa M, Arakawa T, Kadowaki T, Saito T. The effect of mineral trioxide aggregate on the mineralization ability of rat dental pulp cells: an in vitro study. J Endod. 2008; 34:1057–1060.
Article
32. Wozney JM, Rosen V. Bone morphogenetic protein and bone morphogenetic protein gene family in bone formation and repair. Clin Orthop Relat Res. 1998; 346:26–37.
Article
33. Takeda K, Oida S, Goseki M, Iimura T, Maruoka Y, Amagasa T, Sasaki S. Expression of bone morphogenetic protein genes in the human dental pulp cells. Bone. 1994; 15:467–470.
Article
34. Zhang Q, Wang X, Chen Z, Liu G, Chen Z. Semi-quantitative RT-PCR analysis of LIM mineralization protein 1 and its associated molecules in cultured human dental pulp cells. Arch Oral Biol. 2007; 52:720–726.
Article
35. Matsui S, Takeuchi H, Tsujimoto Y, Matsushima K. Effects of Smads and BMPs induced by Ga-Al-As laser irradiation on calcification ability of human dental pulp cells. J Oral Sci. 2008; 50:75–81.
Article
36. Imamura T, Takase M, Nishihara A, Oeda E, Hanai J, Kawabata M, Miyazono K. Smad6 inhibits signaling by the TGF-βsuperfamily. Nature. 1997; 389:622–626.
37. Lawler J. The functions of thrombospondin-1 and-2. Curr Opin Cell Biol. 2000; 12:634–640.
Article
38. Murphy-Ullrich JE, Schultz-Cherry S, Ho¨o¨k M. Transforming growth factor-beta complexes with thrombospondin. Mol Biol Cell. 1992; 3:181–188.
Article
39. Ueno A, Yamashita K, Nagata T, Tsurumi C, Miwa Y, Kitamura S, Inoue H. cDNA cloning of bovine thrombospondin 1 and its expression in odontoblasts and predentin. Biochim Biophys Acta. 1998; 1382:17–22.
Article
40. Neuhaus SJ, Byers MR. Endothelin receptors and endothelin-1 in developing rat teeth. Arch Oral Biol. 2007; 52:655–662.
Article
41. Yan Y, Liu Z, Zhang WG. In vitro study of the effects of endothelin-1 on human dental pulp cells. Chin J Dent Res. 1999; 2:5–13.
42. Suga K, Saitoh M, Fukushima S, Takahashi K, Nara H, Yasuda S, Miyata K. Interleukin-11 induces osteoblast differentiation and acts synergistically with bone morphogenetic protein-2 in C3H10T1/2 cells. J Interferon Cytokine Res. 2001; 21:695–707.
Article
43. Takeuchi Y, Watanabe S, Ishii G, Takeda S, Nakayama K, Fukumoto S, Kaneta Y, Inoue D, Matsumoto T, Harigaya K, Fujita T. Interleukin-11 as a stimulatory factor for bone formation prevents bone loss with advancing age in mice. J Biol Chem. 2002; 277:49011–49018.
Article
44. Takayanaqi H, Kim S, Koqa T, Nishina H, Isshiki M, Yoshida H, Saiura A, Isobe M, Yokochi T, Inoue J, Wagner EF, Mak TW, Kodama T, Taniguchi T. Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclast. Dev Cell. 2002; 3:889–901.
45. Grigoriadis AE, Wang ZQ, Cecchini MG, Hofstetter W, Felix R, Fleisch HA, Wagner EF. C-Fos: a key regulator of osteoclast-macrophage lineage determination and bone remodeling. Science. 1994; 266:443–448.
Article
46. Grigoriadis AE, Schellander K, Wang ZQ, Wagner EF. Osteoblasts are target cells for transformation in c-fos transgenic mice. J Cell Biol. 1993; 122:685–701.
Article
47. Gruda MC, van Amsterdam J, Rizzo CA, Durham SK, Lira S, Bravo R. Expression of FosB during mouse development: normal development of FosB knockout mice. Oncogene. 1996; 12:2177–2185.
48. Smith AJ, Murray PE, Lumley PJ. Preserving the vital pulp in operative dentistry: 1. a biological approach. Dent Update. 2002; 29:64–69.
Article
49. Keyt BA, Nguyen HV, Berleau LT, Duarte CM, Park J, Chen H, Ferrara N. Identification of vascular endothelial growth factor determinants for binding KDR and Flt-1 receptors: generation of receptorselective VEGF variants by site-directed mutagenesis. J Biol Chem. 1996; 271:5638–5646.
50. Matsushita K, Motani R, Sakuta T, Yamaguchi N, Koga T, Matsuo K, Nagaoka S, Abeyama K, Maruyama I, Torii M. The role of vascular endothelial growth factor in human dental pulp cells: induction of chemotaxis, proliferation, and differentiation and activation of the AP-1-dependent signaling pathway. J Dent Res. 2000; 79:1596–1603.
Article
51. Roberts-Clark DJ, Smith AJ. Angiogenic growth factors in human dentine matrix. Arch Oral Biol. 2000; 45:1013–1016.
Article
52. Ribatti D. The crucial role of vascular permeability fac-tor/vascular endothelial growth factor in angiogenesis: a historical review. Br J Haematol. 2005; 128:303–309.
Article
53. Heissig B, Hattori K, Friedrich M, Rafii S, Werb Z. Angiogenesis: vascular remodeling of the extracellular matrix involves metalloproteinases. Curr Opin Hematol. 2003; 10:136–141.
Article
54. Seo DW, Li H, Guedez L, Wingfield PT, Diaz T, Salloum R, Wei BY, Stetler-Stevenson WG. TIMP-2 mediated inhibition of angiogenesis: an MMP-independent mechanism. Cell. 2003; 114:171–180.
55. Murphy AN, Unsworth EJ, Stetler-Stevenson WG. Tissue inhibitor of metalloproteinases-2 inhibits bFGF-induced human microvascular endothelial cell proliferation. J Cell Physiol. 1993; 157:351–358.
Article
56. Mochida Y, Duarte WR, Tanzawa H, Paschalis EP, Yamauchi M. Decorin modulates matrix mineralization in vitro. Biochem Biophys Res Commun. 2003; 305:6–9.
Article
57. Alini M, Marriott A, Chen T, Abe S, Poole AR. A novel angiogenic molecule produced at the time of chondrocyte hypertrophy during endochondral bone formation. Dev Biol. 1996; 176:124–132.
Article
58. Felszeghy S, Hollo′ K, Mo′dis L, Lammi MJ. Type X collagen in human enamel development: a possible role in mineralization. Acta Odontol Scand. 2000; 58:171–176.
Article
59. Deutsch D, Palmon A, Fisher LW, Kolodny N, Termine JD, Young MF. Sequencing of bovine enamelin (“tuftelin”) a novel acidic enamel protein. J Biol Chem. 1991; 266:16021–10628.
Article
60. Paine CT, Paine ML, Luo W, Okamoto CT, Lyngstadaas SP, Snead ML. A tuftelin-interacting protein (TIP39) localizes to the apical secretory pole of mouse ameloblasts. J Biol Chem. 2000; 275:22284–22292.
Article
61. Otterbein LE, Choi AE. Heme oxygenase: colors of defense against cellular stress. Am J Physiol Lung Cell Mol Physiol. 2000; 279:L1029–1037.
Article
62. Foresti R, Motterlini R. The heme oxygenase pathway and its interaction with nitric oxide in the control of cellular homeostasis. Free Radic Res. 1999; 31:459–475.
Article
63. Min KS, Lee HJ, Kim SH, Lee SK, Kim HR, Pae HO, Chung HT, Shin HI, Lee SK, Kim EC. Hydrogen peroxide induces heme oxygenase-1 and dentin sialophos-phoprotein mRNA in human pulp cells. J Endod. 2008; 34:983–989.
Article
64. Min KS, Kwon YY, Lee HJ, Lee SK, Kang KH, Lee SK, Kim EC. Effects of proinflammatory cytokines on the expression of mineralization markers and heme oxygenase-1 in human pulp cells. J Endod. 2006; 32:39–43.
Article
65. Krebs DL, Hilton DJ. SOCS proteins: negative regulators of cytokine signaling. Stem Cells. 2001; 19:378–387.
Article
66. Machado FS, Johndrow JE, Esper L, Dias A, Bafica A, Serhan CN, Aliberti J. Anti-inflammatory actions of lipoxin A(4) and aspirin-triggered lipoxin are SOCS-2 dependent. Nat Med. 2006; 12:330–334.
Article
67. Alexander WS, Hilton DJ. The role of suppressors of cytokine signaling (SOCS) proteins in regulation of the immune response. Annu Rev Immunol. 2004; 22:503–529.
Article
68. Menezes R, Garlet TP, Trombone AP, Repeke CE, Letra A, Granjeiro JM, Campanelli AP, Garlet GP. The potential role of suppressors of cytokine signaling in the attenuation of inflammatory reaction and alveolar bone loss associated with apical periodontitis. J Endod. 2008; 34:1480–1484.
Article
69. Schrem H, Klempnauer J, Borlak J. Liver-enriched transcription factors in liver fuction and development. Part II: The C/EBPs and D site binding protein in cell cycle control, carcinogenesis, circadian gene regulation, liver regulation, apoptosis, and liver-specific gene regulation. Pharmacol Rev. 2004; 56:291–330.
70. Liu YW, Chen CC, Wang JM, Chang WC, Huang YC, Chung SY, Chen BK, Hung JJ. Role of transcriptional factors Sp1, c-Rel, and c-Jun in LPS-induced C/EBPdelta gene expression of mouse macrophages. Cell Mol Life Sci. 2007; 64:3282–3294.
71. Caivano M, Gorgoni B, Cohen P, Poli V. The induction of cyclooxygenage-2 mRNA in macrophages is biphasic and requires both CCAAT/enhancer-binding protein beta (C/EBP beta) and C/EBP delta transcription factors. J Biol Chem. 2001; 276:48693–48701.